Interv Akut Kardiol. 2009;8(3):119-120

Rhythm control or ventricular response control in treating atrial fibrilation ?

Tomáš Janota
III. interní klinika VFN a 1. LF UK, Praha

-

Keywords: -

Published: July 15, 2009  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Janota T. Rhythm control or ventricular response control in treating atrial fibrilation ? Interv Akut Kardiol. 2009;8(3):119-120.
Share...
Download citation
  • BibTeX (.bib)
  • Bookends (.ris)
  • EasyBib (.ris)
  • EndNote (.enw)
  • EndNote 8 (.xml)
  • ISI WoS (.isi)
  • Medlars (.medlars)
  • Mendeley (.ris)
  • MODS (.xml)
  • Papers (.ris)
  • RefWorks (.txt)
  • RefManager (.ris)
  • RIS (.ris)
  • MS Word (.xml)
  • Zotero (.ris)
    • Open full article

    References

    1. Tsang TSM, Petty GS, BarnesME, et al. The prevalence of atrial fibrillation in incident stroke cases and matched population controls in Rochester, Minnesota. Changes over 3 decades. J Am Coll Cardiol 2003; 42: 93-100. Go to original source... Go to PubMed...
    2. Wattigney WA, Mensah GA, Croft JB. Increasing trends in hospitalization for atrial fibrillation in the United States, 1985 through 1999. Implications for primary prevention. Circulation 2003; 108: 711-716. Go to original source... Go to PubMed...
    3. Benjamin EJ, Wolf PA, D'Agostino RB, et al. Impact of atrial fibrillation on the risk of death: the Framingham Heart Study. Circulation 1998; 98: 946-952. Go to original source... Go to PubMed...
    4. Flegel KM, Shipley MJ, Rose G. Risk of stroke in non-rheumatic atrial fibrillation. Lancet 1987; I(8532): 526-529. Go to original source... Go to PubMed...
    5. Wolf PA, Abbott RD, Kannel WB. Atrial fibrillation as an independent risk factor for stroke: the Framingham Study. Stroke 1991; 22: 983-988. Go to original source... Go to PubMed...
    6. Kannel WB, Abbott RD, Savage DD, et al. Coronary heart disease and atrial fibrillation: the Framingham Study. Am Heart J 1983; 106: 389-396. Go to original source... Go to PubMed...
    7. Hohnloser SH, Kuck KH, Lilienthal J. Rhythm or rate control in atrial fibrillation. Pharmacological Intervention in Atrial Fibrillation (PIAF): a randomized trial. Lancet 2000; 356: 1789-1794. Go to original source... Go to PubMed...
    8. Carlsson J, Miketic S, Windeler J, et al. Randomized Trial of Rate-Control Versus Rhythm-Control in Persistent Atrial Fibrillation. The Strategies of Treatment of Atrial Fibrillation (STAF) Study. JACC 2003; 41: 1690-1696. Go to original source... Go to PubMed...
    9. Agens VE, Crijns HJGM, Van Veldhuisen DJ, et al. Rate control versus rhythm control for patients with persistent atrial fibrillation with mild to moderate heart failure: Results from the RAte Control versus Electrical cardioversion (RACE) study. Am Heart J 2005; 149: 1106-1111. Go to original source... Go to PubMed...
    10. Curtis AB, Gersh BJ, Corley SD, et al. Clinical factors that influence response to treatment strategies in atrial fibrillation: The Atrial Fibrillation Follow-up Investigation of Rhythm Management (AFFIRM) Study. Am Heart J 2005; 149: 645-649. Go to original source... Go to PubMed...
    11. Rate Control vs Rhythm Control in Patients With Nonvalvular Persistent Atrial Fibrillation. Opolski G, Torbicki A, Kosior DA, et al. Chest 2004; 126: 476-486. Go to original source... Go to PubMed...
    12. Roy D, Talajic M, Dubuc M, et al. Atrial fibrillation and congestive heart failure Curr Opin Cardiol 2009; 24: 29-34. Go to original source... Go to PubMed...
    13. Bardy GH, Lee KL, Mark DB, et al. Amiodarone or an implantable cardioverterdefibrillator for congestive heart failure. New Engl J Med 2005; 352: 225-237. Go to original source... Go to PubMed...
    14. Kober L, Torp-Pedersen C, McMurray JJV, et al. Increased mortality after dronedarone therapy for severe heart failure. N Engl J Med 2008; 358: 2678-2687. Go to original source... Go to PubMed...
    15. Hohnloser SH, Crijns HJ, van Eickels M, et al. Effect of dronedarone on cardiovascular event in atrial fibrillation. N Engl J Med 2009; 360: 668-678. Go to original source... Go to PubMed...
    16. Hsu LF, Jais P, Sanders P, et al. Catheter ablation for atrial fibrillation in congestive heart failure. N Engl J Med 2004; 351: 2373-2383. Go to original source... Go to PubMed...
    17. Kalus JS, Coleman CI, White CM, The impact of suppressing the renin-angiotensin system atrial fibrillation. J Clin Pharmacol 2006; 46: 21-28. Go to original source... Go to PubMed...
    18. Singh SN, Tang XCH, Singh BN, et al. Quality of Life and Exercise Performance in Patients in Sinus Rhythm versus Persistent Atrial Fibrillation. JACC 2006; 48: 721-730. Go to original source... Go to PubMed...
    19. Cappato R, Calkins H, Chen SA, et al. Worldwide survey on the methods, efficacy, and safety of catheter ablation for human atrial fibrillation. Circulation. 2005; 111: 1100-1105. Go to original source... Go to PubMed...
    20. Crijns HJGM. Rate versus Rhythm Control in Patients with Atrial Fibrillation. What the Trials Really Say. Drugs 2005; 65: 1651-1667. Go to original source... Go to PubMed...

    Return to the content


    Interventional Cardiology

    Madam, Sir,
    please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
    Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

    I declare:

    1. that I have met the above instruction
    2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited

    No
    Yes

    If your statement is not true, please be aware
    that brings the risk of danger to their health or the health of others.